Abstract
Huntington’s disease (HD) is a genetic neurodegenerative progressive and fatal disease characterized by motor disorder, cognitive impairment, and behavioral problems, caused by expanded repeats of CAG trinucleotides in the HTT gene. The aim of this study was to investigate the influence of TBP gene CAG/CAA repeats in conjunction with HTT gene CAG repeats, on the age at HD onset in Brazilian individuals. Individuals diagnosed as molecularly negative for HD presented 29–39 TBP CAG/CAA. Their most frequent allele had 36 repeats. In individuals diagnosed as molecularly positive for HD, a range of 25–40 TBP CAG/ CAA was found. The most frequent TBP allele had 38 repeats. We also conducted TBP direct Sanger sequencing of some samples which demonstrated other four TBP structures different from the basic TBP structure and others reported in the literature. The HTT expanded CAG and TBP CAG/CAA repeat sizes jointly explained 66% of the age at onset (AO) in our HD patients. The strongest variable in the model associated with AO was the number of expanded HTT CAG repeats. The difference between the association of HD AO with HTT expanded CAG together with TBP CAG/CAA and the association of HD AO with HTT expanded CAG was 0.001 (∆R2). Therefore, we found a weak association (0.1%) of TBP CAG/CAA repeats on HD AO, if any.
Similar content being viewed by others
References
Agostinho LA, Rocha CF, Medina-Acosta E, Barboza HN, da Silva AF, Pereira SP, da Silva Idos S, Paradela ER, Figueiredo AL, Nogueira Ede M, Alvarenga RM, Hernan Cabello P, dos Santos SR, Paiva CL (2012) Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington’s disease. J Hum Genet 57(12):796–803
Andrew SE, Goldberg YP, Theilmann J, Zeisler J, Hayden MR (1994) A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing Hum Mol Genet 3:65-67. https://doi.org/10.1093/hmg/3.1.65
Bassi S, Tripathi T, Monziani A, Di Leva F, Biagioli M (2017) Epigenetics of Huntington’s Disease. Adv Exp Med Biol 978:277–299
Cha JH (2000) Transcriptional dysregulation in Huntington’s disease. Trends Neurosci 23(9):387–392
Chen Z, Zheng C, Long Z, Cao L, Li X, Shang H, Yin X, Zhang B, Liu J, Ding D, Peng Y, Wang C, Peng H, Ye W, Qiu R, Pan Q, Xia K, Chen S, Sequeiros J, Ashizawa T, Klockgether T, Tang B, Jiang H (2016) Chinese Clinical Research Cooperative Group for Spinocerebellar. (CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China. Brain England 139:e41
Djousse L, Knowlton B, Hayden M, Almqvist EW, Brinkman R, Ross C, Margolis R, Rosenblatt A, Durr A, Dode C, Morrison PJ, Novelletto A, Frontali M, Trent RJ, McCusker E, Gomez-Tortosa E, Mayo D, Jones R, Zanko A, Nance M, Abramson R, Suchowersky O, Paulsen J, Harrison M, Yang Q, Cupples LA, Gusella JF, MacDonald ME, Myers RH (2003) Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet A 119a(3):279–282
Durr A (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 9(9):885–894
Fujigasaki H et al (2001) CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia Brain 124:1939-1947. https://doi.org/10.1093/brain/124.10.1939
Goold R, Flower M, Moss DH, Medway C, Wood-Kaczmar A, Andre R, Farshim P, Bates GP, Holmans P, Jones L, Tabrizi SJ (2019) FAN1 modifies Huntington’s disease progression by stabilizing the expanded HTT CAG repeat. Hum Mol Genet 28(4):650–661
Gostout B, Liu Q, Sommer SS (1993) Cryptic repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY(i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes. Am J Hum Genet 52(6):1182–1190
Gusella JF, MacDonald ME (2009) Huntington’s disease: the case for genetic modifiers. Genome Med 1(8):80
Gusella JF, MacDonald ME, Lee JM (2014) Genetic modifiers of Huntington’s disease. Mov Disord 29(11):1359–1365
Hmida-Ben Brahim D, Chourabi M, Ben Amor S, Harrabi I, Trabelsi S, Haddaji-Mastouri M, Gribaa M, Sassi S, Gahbiche FE, Lamouchi T, Mougou-Zereli S, Ben Ammou S, Saad A (2014) Modulation at age of onset in tunisian huntington disease patients: implication of new modifier genes. Genet Res Int 210418
Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP, MacDonald ME, Gusella JF (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet 24(4):217–233
Imbert G, Trottier Y, Beckmann J, Mandel JL (1994) The gene for the TATA binding protein (TBP) that contains a highly polymorphic protein coding CAG repeat maps to 6q27. Genomics 21(3):667–668
Kay C, Collins JA, Caron NS, Agostinho LA, Findlay-Black H, Casal L, Sumathipala D, Dissanayake VHW, Cornejo-Olivas M, Baine F, Krause A, Greenberg JL, Paiva CLA, Squitieri F, Hayden MR (2019) A comprehensive haplotype-targeting strategy for allele-specific HTT suppression in Huntington disease. Am J Hum Genet 105(6):1112–1125
Klockgether T, Evert B (1998) Genes involved in hereditary ataxias. Trends Neurosci 21(9):413–418
Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, Yamada M, Takahashi H, Tsuji S (1999) A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?. Hum Mol Genet 8(11):2047–2053
Lin X, Antalffy B, Kang D, Orr HT, Zoghbi HY (2000) Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci 3(2):157–163
Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22(5):1277–1287
Marti E (2016) RNA toxicity induced by expanded CAG repeats in Huntington’s disease. Brain Pathol 26(6):779–786
Myers RH, MacDonald ME, Koroshetz WJ, Duyao MP, Ambrose CM, Taylor SA, Barnes G, Srinidhi J, Lin CS, Whaley WL et al (1993) De novo expansion of a (CAG)n repeat in sporadic Huntington’s disease. Nat Genet 5(2):168–173
Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, Ikeda S, Tsuji S, Kanazawa I (2001) SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10(14):1441–1448
Nalavade R, Griesche N, Ryan DP, Hildebrand S, Krauss S (2013) Mechanisms of RNA-induced toxicity in CAG repeat disorders. Cell Death Dis 4:e752
Ohi K, Hashimoto R, Yasuda Y, Kiribayashi M, Iike N, Yoshida T, Azechi M, Ikezawa K, Takahashi H, Morihara T, Ishii R, Tagami S, Iwase M, Okochi M, Kamino K, Kazui H, Tanaka T, Kudo T, Takeda M (2009) TATA box-binding protein gene is associated with risk for schizophrenia, age at onset and prefrontal function. Genes Brain Behav 8(4):473–480
Orr HT (2012) Polyglutamine neurodegeneration: expanded glutamines enhance native functions. Curr Opin Genet Dev 22(3):251–255
Reid SJ, Whittaker DJ, Greenwood D, Snell RG (2009) A splice variant of the TATA-box binding protein encoding the polyglutamine-containing N-terminal domain that accumulates in Alzheimer’s disease. Brain Res 1268:190–199. https://doi.org/10.1016/j.brainres.2009.03.004
Rubinsztein DC, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E, Craufurd D (1997) Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A 94(8):3872–3876
Rubinsztein DC, Leggo J, Crow TJ, DeLisi LE, Walsh C, Jain S, Paykel ES (1996) Analysis of polyglutamine-coding repeats in the TATA-binding protein in different human populations and in patients with schizophrenia and bipolar affective disorder. Am J Med Genet 67(5):495–498
Silveira I et al. (2002) Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus Arch Neurol 59:623-629. https://doi.org/10.1001/archneur.59.4.623
Stuitje G, van Belzen MJ, Gardiner SL, van Roon-Mom WMC, Boogaard MW, RIotEHD Network, Tabrizi SJ, Roos RAC, Aziz NA (2017) Age of onset in Huntington’s disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes. Brain England 140:e42
Tezenas du Montcel S, Durr A, Bauer P, Figueroa KP, Ichikawa Y, Brussino A, Forlani S, Rakowicz M, Schols L, Mariotti C, van de Warrenburg BP, Orsi L, Giunti P, Filla A, Szymanski S, Klockgether T, Berciano J, Pandolfo M, Boesch S, Melegh B, Timmann D, Mandich P, Camuzat A, Goto J, Ashizawa T, Cazeneuve C, Tsuji S, Pulst SM, Brusco A, Riess O, Brice A, Stevanin G (2014) Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain 137(Pt 9):2444–2455
The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72(6):971–983
Tomiuk J, Bachmann L, Bauer C, Rolfs A, Schols L, Roos C, Zischler H, Schuler MM, Bruntner S, Riess O, Bauer P (2007) Repeat expansion in spinocerebellar ataxia type 17 alleles of the TATA-box binding protein gene: an evolutionary approach. Eur J Hum Genet 15(1):81–87
van Roon-Mom WM, Reid SJ, Faull RL, Snell RG (2005) TATA-binding protein in neurodegenerative disease. Neuroscience 133(4):863–872
van Roon-Mom WM, Reid SJ, Jones AL, MacDonald ME, Faull RL, Snell RG (2002) Insoluble TATA-binding protein accumulation in Huntington’s disease cortex. Brain Res Mol Brain Res 109(1–2):1–10
Vuono R, Winder-Rhodes S, de Silva R, Cisbani G, Drouin-Ouellet J, Spillantini MG, Cicchetti F, Barker RA (2015) The role of tau in the pathological process and clinical expression of Huntington’s disease. Brain 138(Pt 7):1907–1918
Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayan J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, Wiktorski S, Hodes ME, Conneally PM, Penney JB, Gusella J, Cha JH, Irizarry M, Rosas D, Hersch S, Hollingsworth Z, MacDonald M, Young AB, Andresen JM, Housman DE, De Young MM, Bonilla E, Stillings T, Negrette A, Snodgrass SR, Martinez-Jaurrieta MD, Ramos-Arroyo MA, Bickham J, Ramos JS, Marshall F, Shoulson I, Rey GJ, Feigin A, Arnheim N, Acevedo-Cruz A, Acosta L, Alvir J, Fischbeck K, Thompson LM, Young A, Dure L, O’Brien CJ, Paulsen J, Brickman A, Krch D, Peery S, Hogarth P, Higgins DS Jr, Landwehrmeyer B (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proc Natl Acad Sci U S A 101(10):3498–3503
Wright GEB, Collins JA, Kay C, McDonald C, Dolzhenko E, Xia Q, Becanovic K, Drogemoller BI, Semaka A, Nguyen CM, Trost B, Richards F, Bijlsma EK, Squitieri F, Ross CJD, Scherer SW, Eberle MA, Yuen RKC, Hayden MR (2019) Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease. Am J Hum Genet 104(6):1116–1126
Wu YR, Fung HC, Lee-Chen GJ, Gwinn-Hardy K, Ro LS, Chen ST, Hsieh-Li HM, Lin HY, Lin CY, Li SN, Chen CM (2005) Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases. J Neural Transm (vienna) 112(4):539–546
Zuhlke C, Hellenbroich Y, Dalski A, Kononowa N, Hagenah J, Vieregge P, Riess O, Klein C, Schwinger E (2001) Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet 9(3):160–164
Acknowledgements
Many thanks are due to the DNA Sequencing and Fragment Analysis Platform of IOC/FIOCRUZ/RJ and to the Centre for Molecular Medicine and Therapeutics (UBC), Vancouver, Canada, for the help with DNA sequencing. We also thank Dr. Suely Rodrigues dos Santos, Dr. Mariana Spitz, Dr. João Santos Pereira, and Dr. Luiz Felipe Vasconcellos for the referral of some patients, as well as the Brazilian Huntington’s Disease Association (ABH). Finally, we thank all the patients and their families for participating in this investigation.
Funding
This work was supported by CAPES (scholarships for I.S.S., T.A.A., and L.A.A. during their post-graduate studies), FAPERJ (grant no. E-26/010.000956/2016 to C.L.A.P), UNIRIO, and FINEP.
Author information
Authors and Affiliations
Contributions
Agostinho, Da Silva and Apolinário were responsible for the experiments. All authors contributed to the result analysis, statistical analysis, and wrote the manuscript. Agostinho and Paiva reviewed the final version of the article.
Corresponding author
Ethics declarations
Ethics Approval
This study was approved by the HUGG Research Ethics Committee, Rio de Janeiro, Brazil, under the number CAAE 26387113.1.0000.5258.
Consent to Participate
All the participants in this investigation signed the “Informed Consent” form.
Consent for Publication
All participants gave written informed consent for publication in journal article form, as long as information was anonymized.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
da Silva, I.d.S., Apolinário, T.A., de Andrade Agostinho, L. et al. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington’s Disease Age at Onset in a Brazilian Sample. J Mol Neurosci 72, 1116–1124 (2022). https://doi.org/10.1007/s12031-021-01938-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-021-01938-z